Literature DB >> 17586286

Gene therapy for Parkinson's disease: early data.

A Jon Stoessl1.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17586286     DOI： 10.1016/S0140-6736(07)60957-X

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Countering amyloid polymorphism and drug resistance with minimal drug cocktails.

Authors:  Martin L Duennwald; James Shorter
Journal:  Prion       Date:  2010-10-12       Impact factor: 3.931

Review 2.  Applying Hsp104 to protein-misfolding disorders.

Authors:  Shilpa Vashist; Mimi Cushman; James Shorter
Journal:  Biochem Cell Biol       Date:  2010-02       Impact factor: 3.626

Review 3.  Available and emerging treatments for Parkinson's disease: a review.

Authors:  Patrick Hickey; Mark Stacy
Journal:  Drug Des Devel Ther       Date:  2011-05-02       Impact factor: 4.162

4.  Positron emission tomography imaging demonstrates correlation between behavioral recovery and correction of dopamine neurotransmission after gene therapy.

Authors:  Ludovic Leriche; Tomas Björklund; Nathalie Breysse; Laurent Besret; Marie-Claude Grégoire; Thomas Carlsson; Frédéric Dollé; Ronald J Mandel; Nicole Déglon; Philippe Hantraye; Deniz Kirik
Journal:  J Neurosci       Date:  2009-02-04       Impact factor: 6.167

5.  Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.

Authors:  Mimi Cushman-Nick; Nancy M Bonini; James Shorter
Journal:  PLoS Genet       Date:  2013-09-05       Impact factor: 5.917
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.